These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 29212355)
41. Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016). Bourcier J; Heudes PM; Morio F; Gastinne T; Chevallier P; Rialland-Battisti F; Garandeau C; Danner-Boucher I; Le Pape P; Frampas E; Moreau P; Defrance C; Peterlin P Mycoses; 2017 Aug; 60(8):526-533. PubMed ID: 28429890 [TBL] [Abstract][Full Text] [Related]
42. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies. Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294 [TBL] [Abstract][Full Text] [Related]
43. [Early computed tomography signs in diagnosis of some pulmonary mycoses in myelotoxic agranulocytosis]. Gotman LN; Iatsyk GA; Kliasova GA Ter Arkh; 2008; 80(7):30-3. PubMed ID: 18763591 [TBL] [Abstract][Full Text] [Related]
44. Reversed halo sign in acute pulmonary embolism and infarction. Casullo J; Semionov A Acta Radiol; 2013 Jun; 54(5):505-10. PubMed ID: 23395814 [TBL] [Abstract][Full Text] [Related]
45. 64 multidetector CT findings of influenza A (H1N1) virus in patients with hematologic malignancies. El-Badrawy A; Zeidan A; Ebrahim MA Acta Radiol; 2012 Jul; 53(6):662-7. PubMed ID: 22734081 [TBL] [Abstract][Full Text] [Related]
46. Significance of the Reverse Halo Sign in Immunocompromised Patients. Thomas R; Madan R; Gooptu M; Hatabu H; Hammer MM AJR Am J Roentgenol; 2019 Sep; 213(3):549-554. PubMed ID: 31039026 [No Abstract] [Full Text] [Related]
47. Pulmonary invasive aspergillosis and candidiasis in immunocompromised patients: a comparative study of the high-resolution CT findings. Althoff Souza C; Müller NL; Marchiori E; Escuissato DL; Franquet T J Thorac Imaging; 2006 Aug; 21(3):184-9. PubMed ID: 16915062 [TBL] [Abstract][Full Text] [Related]
48. Computed tomography and clinical features of invasive pulmonary aspergillosis in liver transplant recipients. Qin J; Meng X; Fang Y; Xu C; Zhu K; Wu B; An Y; Shan H J Thorac Imaging; 2012 Mar; 27(2):107-12. PubMed ID: 21364471 [TBL] [Abstract][Full Text] [Related]
49. Pulmonary histoplasmosis presenting with the reversed halo sign on high-resolution CT scan. Marchiori E; Melo SMD; Vianna FG; Melo BSD; Melo SSD; Zanetti G Chest; 2011 Sep; 140(3):789-791. PubMed ID: 21896523 [TBL] [Abstract][Full Text] [Related]
50. Pulmonary complications in children with hematologic malignancies: accuracy of diagnosis with chest radiography and CT. Winer-Muram HT; Arheart KL; Jennings SG; Rubin SA; Kauffman WM; Slobod KS Radiology; 1997 Sep; 204(3):643-9. PubMed ID: 9280238 [TBL] [Abstract][Full Text] [Related]
51. CT-guided biopsies in lung infections in patients with haematological malignancies. de Bazelaire C; Coffin A; Cohen-Zarade S; de Margerie-Mellon C; Scemama A; Sabatier F; Calmon R; de Kerviler E Diagn Interv Imaging; 2013 Feb; 94(2):202-15. PubMed ID: 23352879 [TBL] [Abstract][Full Text] [Related]
52. CT-guided percutaneous lung biopsies in patients with haematologic malignancies and undiagnosed pulmonary lesions. Gupta S; Sultenfuss M; Romaguera JE; Ensor J; Krishnamurthy S; Wallace MJ; Ahrar K; Madoff DC; Murthy R; Hicks ME Hematol Oncol; 2010 Jun; 28(2):75-81. PubMed ID: 19728397 [TBL] [Abstract][Full Text] [Related]
53. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Kim K; Lee MH; Kim J; Lee KS; Kim SM; Jung MP; Han J; Sung KW; Kim WS; Jung CW; Yoon SS; Im YH; Kang WK; Park K; Park CH Am J Hematol; 2002 Oct; 71(2):75-9. PubMed ID: 12353303 [TBL] [Abstract][Full Text] [Related]
54. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study. Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655 [TBL] [Abstract][Full Text] [Related]
55. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Chamilos G; Marom EM; Lewis RE; Lionakis MS; Kontoyiannis DP Clin Infect Dis; 2005 Jul; 41(1):60-6. PubMed ID: 15937764 [TBL] [Abstract][Full Text] [Related]
56. CT Halo sign: A systematic review. Ray A; Mittal A; Vyas S Eur J Radiol; 2020 Mar; 124():108843. PubMed ID: 32007819 [TBL] [Abstract][Full Text] [Related]
57. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies. Hoenigl M; Zollner-Schwetz I; Sill H; Linkesch W; Lass-Flörl C; Schnedl WJ; Krause R Mycoses; 2011 Sep; 54(5):454-9. PubMed ID: 20406398 [TBL] [Abstract][Full Text] [Related]
58. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009). Klingspor L; Saaedi B; Ljungman P; Szakos A Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371 [TBL] [Abstract][Full Text] [Related]
59. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy. Hoenigl M; Seeber K; Koidl C; Buzina W; Wölfler A; Duettmann W; Wagner J; Strenger V; Krause R Mycoses; 2013 Jul; 56(4):471-6. PubMed ID: 23432536 [TBL] [Abstract][Full Text] [Related]
60. A risk prediction score for invasive mold disease in patients with hematological malignancies. Stanzani M; Lewis RE; Fiacchini M; Ricci P; Tumietto F; Viale P; Ambretti S; Baccarani M; Cavo M; Vianelli N PLoS One; 2013; 8(9):e75531. PubMed ID: 24086555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]